The Global Fund, the Government of the Republic of Congo, and health partners launched two new grants to strengthen prevention and treatment services to fight HIV, TB, and malaria and build resilient and sustainable systems for health.
The two grants, worth over US$64 million, represent a 97% increase from the previous allocation and will run from 2021-2023. UNDP will implement the HIV and tuberculosis grant, while Catholic Relief Services will implement the malaria grant.
To date, with the support of donors and partners, more than US$122 million has been invested in the Congo. This has helped expand access to HIV and TB treatment.
Approximately 26,000 people living with HIV are currently receiving antiretroviral therapy and 12,000 patients are tested and treated for TB every year. In 2019 alone, more than 2.6 million mosquito nets have been distributed to protect families against malaria.
UNDP Administrator Steiner, uttered: “This is a critical time for the Republic of the Congo, as the COVID-19 pandemic threatens to reverse the hard-won health and development gains of recent years. The Global Fund grants will play a pivotal role in supporting the Ministry of Health to strengthen the health system in the country and help people access the vital services they need.”
Sands, Executive Director of the Global Fund, said: “These new investments represent an important milestone in our partnership with the Government of the Congo and our health partners. We acknowledge the progress made by the country over the past three years and we must work even harder to step up the fight against HIV, TB and malaria and strengthen health systems. We must all rise to the challenge.”
The HIV grant in Congo intends to significantly increase the number of people living with HIV who know their HIV status and expand access to lifesaving antiretroviral therapy, particularly for pregnant women.
The TB component of the grant aims to boost the national TB response, increase the notification of new TB cases and reach a 90% treatment success rate by 2023, in line with WHO’s End TB Strategy.
The grant will also support the country’s efforts to improve treatment success for multidrug-resistant TB patients. The malaria grant will support the country’s goal to distribute 3.5 million mosquito nets by 2023 and expand access to quality malaria diagnostics and treatment tools.